Stat1-independent Induction of SOCS-3 by Interferon-gamma is Mediated by Sustained Activation of Stat3 in Mouse Embryonic Fibroblasts
Overview
Affiliations
Using microarray technology, we previously demonstrated that IFN-gamma induces suppressor of cytokine signaling-3 (SOCS-3) in Stat1-/- mouse embryonic fibroblasts and bone marrow-derived macrophages. In this study, we have investigated the mechanism by which SOCS-3 is induced by Stat1-independent signal transduction pathway. Tyrosine kinases Jak1 and Jak2 are required for SOCS-3 induction by IFN-gamma in mouse embryonic fibroblasts. IFN-gamma stimulated strong and sustained activation of Stat1 whereas Stat3 activation was weak and transient in wild-type fibroblasts. In contrast, Stat3 is activated strongly and in a sustained manner in Stat1-/- fibroblasts. The Src kinase inhibitor SU6656 suppressed IFN-gamma activation of Stat3 in both wild-type and Stat1-/- fibroblasts. However, SU6656 inhibited IFN-gamma induction of SOCS-3 completely in Stat1-/- but not in wild-type fibroblasts. Knock down of Stat3 by short interfering RNA abrogated Stat3 activation and SOCS-3 induction by IFN-gamma in Stat1-/- fibroblasts. In human fibrosarcoma cell line 2fTGH, IFN-gamma activated Stat1 but not Stat3. SOCS-3 induction by IFN-gamma is strictly Stat1-dependent. The Stat1 docking site is required for SOCS-3 induction by IFN-gamma in human lung adenocarcinoma cells. We propose a model in which sustained activation of Stat1 or Stat3 mediates SOCS-3 induction by IFN-gamma in wild-type and Stat1-/- mouse embryonic fibroblasts, respectively.
Sun C, Fujisawa M, Ohara T, Liu Q, Cao C, Yang X J Adv Res. 2022; 35:71-86.
PMID: 35003795 PMC: 8721245. DOI: 10.1016/j.jare.2021.03.014.
SOCS proteins and their roles in the development of glioblastoma.
Dai L, Li Z, Liang W, Hu W, Zhou S, Yang Z Oncol Lett. 2021; 23(1):5.
PMID: 34820004 PMC: 8607235. DOI: 10.3892/ol.2021.13123.
An aberrant STAT pathway is central to COVID-19.
Matsuyama T, Kubli S, Yoshinaga S, Pfeffer K, Mak T Cell Death Differ. 2020; 27(12):3209-3225.
PMID: 33037393 PMC: 7545020. DOI: 10.1038/s41418-020-00633-7.
Liu Y, Wang L, Liu W, Zhang H, Xue J, Zhang Z J Hematol Oncol. 2016; 9(1):69.
PMID: 27516205 PMC: 4982324. DOI: 10.1186/s13045-016-0300-3.
Gomersall A, Phan H, Iacuone S, Li S, Parish R PLoS One. 2015; 10(10):e0140753.
PMID: 26512722 PMC: 4626034. DOI: 10.1371/journal.pone.0140753.